Icon

ZYMAXID (nda022548)- (0.5%)

GATIFLOXACIN ABBVIE
0.5%
Yes No
2020-Feb-20 Expired
None 2013-May-18
None No
ZYMAXID® is a quinolone antimicrobial indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Haemophilus influenzae, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus mitis group, Streptococcus oralis, Streptococcus pneumoniae
4 0 4
Total Other Developers 4
Drugs with Suitability No
0.5% ** ** - - 1
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** *** ***** ******* *********** ****-*, **** **. *-* *** *-*-*, ******* ******** **** ***** **, ****. ****, ******* ****, ****. ****, *********, ****** ******* ******, ***** (***) ***
****** ***** ***** ********* ******* *** (*** *****) *********** *** ******* ******, **********, *** **** (**) *****, ****** ****** (***) ***
****** ****** ***** ******** *** *********** **** ***** *******, **** *****, ***** (**) *****, ****** ****** (***) ***
****** ******* ****** ******** ******* *********** ****** **.*** & ***. ******************, **************** (****), *********** (********), *************, ***** **** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.